Orthostatic hypotension during combination chemotherapy with vincristine (NSC-67574).
D000293:Adolescent; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced*; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000532:radiotherapy; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone